Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
30.64
-0.41 (-1.34%)
Apr 28, 2026, 12:07 PM EDT - Market open
HRMY Revenue
In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth. Harmony Biosciences Holdings had revenue of $243.78M in the quarter ending December 31, 2025, with 21.12% growth.
Revenue (ttm)
$868.45M
Revenue Growth
+21.51%
P/S Ratio
2.07
Revenue / Employee
$2,964,003
Employees
293
Market Cap
1.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 868.45M | 153.72M | 21.51% |
| Dec 31, 2024 | 714.73M | 132.71M | 22.80% |
| Dec 31, 2023 | 582.02M | 144.17M | 32.93% |
| Dec 31, 2022 | 437.86M | 132.42M | 43.35% |
| Dec 31, 2021 | 305.44M | 145.70M | 91.21% |
| Dec 31, 2020 | 159.74M | 153.75M | 2,564.59% |
| Dec 31, 2019 | 6.00M | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Innoviva | 411.33M |
| Vericel | 276.26M |
| AnaptysBio | 234.60M |
| Recursion Pharmaceuticals | 74.68M |
| Nurix Therapeutics | 71.78M |
| Nuvation Bio | 62.90M |
| Taysha Gene Therapies | 9.77M |
HRMY News
- 5 days ago - Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
- 12 days ago - Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting - Business Wire
- 14 days ago - Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer - Business Wire
- 15 days ago - Harmony Biosciences Holdings Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 26 days ago - Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board - Business Wire
- 4 weeks ago - Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 7 weeks ago - Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Harmony Biosciences Holdings Earnings Call Transcript: Q4 2025 - Transcripts